A challenge of cancer treatment is doing our best to ensure that the benefits a medicine brings outweigh the burden of unwanted side effects. Chemotherapy, for example, is a powerful treatment that kills cancer cells, but it damages healthy cells too, leading to side effects like hair loss and tiredness. Monoclonal antibodies are also used to treat cancer and are capable of a more targeted attack on tumour cells.

What if we could combine the targeting power of monoclonal antibodies and the toxic properties of chemotherapy to help the treatment to selectively kill cancer cells? That’s where antibody-drug conjugates (ADCs) come in.

M-EE-00000171

Subscribe to our YouTube channel now: [ Ссылка ]

Get in touch with us:

[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]

Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.

For more information and insights visit: [ Ссылка ]

свернуть